Neumirna Therapeutics ApS — CVR 41696451
Is this your company?
Verify ownership and add your website, description, services, products, logo, socials and more.
Claim & enrichReviews
Loading…
Verified reviews from Søge users
Company relationship network
Building the network…
Node colour = company status · blue dot = person. Edge colour = how they are linked: ownership, management, founder, or a shared phone / e-mail / website. Toggle any relation type off with the filters. Double-click a company to open it.
Active
Founded 2020
CVR
41696451
↗ Datacvr
Status
Active
Company form
Private limited (ApS)
Start date
2020-09-21
Addresses
A.C. Meyers Vænge 15, 2450 København SV
(KØBENHAVN)
Advertising protected
Yes
Industry (2)
Forskning og eksperimentel udvikling indenfor bioteknologi
721100
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
721000
Addresses (2)
Knud Højgaards Vej 9,
2860 Søborg
(GLADSAXE)
2020-09-21
A.C. Meyers Vænge 15,
2450 København SV
(KØBENHAVN)
2020-11-17
Relations (24)
Sten Verland
Chairman
Profile
Mads Spangaard Rasmussen
Board member
Profile
Markus Sakari Kauppinen
Board member
Profile
Lars Hellerung Christiansen
Board member
Profile
Morten Priskorn
Board member
Profile
Janine Terra Erler
ADM. DIR.
Profile
Henrik Valdemar Klitgaard
ADM. DIR.Board member
Profile
Thomas Michael Thestrup
Board member
Profile
ApS KBUS 8 NR. 5329
FoundersLegal owner
Profile
Ownership: 33.33%
· Voting: 33.33%
KR 483 A/S
Auditor
Profile
FONDEN FOR SYDDANSK VÆKSTFREMME
FoundersLegal owner
Profile
Ownership: 5%
· Voting: 5%
Krudtmøllen I ApS
FoundersLegal owner
Profile
Ownership: 5%
· Voting: 5%
Henrik Valdemar Klitgaard Holding ApS
FoundersLegal owner
Profile
Ownership: 10%
· Voting: 10%
Pandion Holding ApS
FoundersLegal owner
Profile
Ownership: 15%
· Voting: 15%
Wyle Solomon
ChairmanLegal owner
Profile
Ownership: 5%
· Voting: 5%
Milla Koistinaho
Board member
Profile
INVIVO VENTURES III, FCRE
Legal owner
Profile
Ownership: 5%
· Voting: 5%
Luis Garcia Pareras
Chairman
Profile
Innovestor Life Science Fund Ky
Legal owner
Profile
Ownership: 10%
· Voting: 10%
Angelini Ventures S.p.A.
Legal owner
Profile
Ownership: 5%
· Voting: 5%
Andreas Wallnöfer
Board member
Profile
Ellen Kinson Donnelly
ADM. DIR.Board member
Profile
Francesco Paolo Di Giorgio
Board member
Profile
Lifecycle (1)
2020-09-21 — now
Employees per month
| Period | Employees | FTE (man-years) |
|---|---|---|
| 2026-04 | 11 | 9 |
| 2026-03 | 11 | 9 |
| 2026-02 | 12 | 9 |
| 2026-01 | 12 | 9 |
| 2025-12 | 12 | 10 |
| 2025-11 | 13 | 11 |
| 2025-10 | 13 | 10 |
| 2025-09 | 13 | 10 |
| 2025-08 | 11 | 9 |
| 2025-07 | 11 | 9 |
| 2025-06 | 11 | 9 |
| 2025-05 | 11 | 10 |
| 2025-04 | 11 | 10 |
| 2025-03 | 10 | 8 |
| 2025-02 | 8 | 7 |
| 2025-01 | 7 | 6 |
| 2024-12 | 7 | 5 |
| 2024-11 | 7 | 5 |
| 2024-10 | 8 | 5 |
| 2024-09 | 6 | 5 |
| 2024-08 | 5 | 4 |
| 2024-07 | 4 | 3 |
| 2024-06 | 4 | 4 |
| 2024-05 | 5 | 4 |
| 2024-04 | 5 | 4 |
| 2024-03 | 5 | 4 |
| 2024-02 | 5 | 4 |
| 2024-01 | 4 | 2 |
| 2023-12 | 4 | 3 |
| 2023-11 | 4 | 3 |
| 2023-10 | 4 | 3 |
| 2023-09 | 4 | 3 |
| 2023-08 | 4 | 3 |
| 2023-07 | 4 | 3 |
| 2023-06 | 4 | 3 |
| 2023-05 | 4 | 3 |
| 2023-04 | 4 | 3 |
| 2023-03 | 4 | 3 |
| 2023-02 | 3 | 3 |
| 2023-01 | 3 | 1.92 |
| 2022-12 | 4 | 4 |
| 2022-11 | 3 | 2 |
| 2022-10 | 3 | 3 |
| 2022-09 | 3 | 2 |
| 2022-08 | 4 | 3 |
| 2022-07 | 2 | 2 |
| 2022-06 | 3 | 3 |
| 2022-05 | 3 | 3 |
| 2022-04 | 3 | 3 |
| 2022-03 | 3 | 3 |
| 2022-02 | 3 | 3 |
| 2022-01 | 2 | 2 |
| 2021-12 | 2 | 2 |
| 2021-11 | 2 | 2 |
| 2021-10 | 2 | 2 |
| 2021-09 | 2 | 2 |
| 2021-08 | 2 | 2 |
| 2021-07 | 2 | 2 |
| 2021-06 | 2 | 2 |
| 2021-05 | 2 | 2 |
| 2021-04 | 2 | 2 |
| 2021-03 | 2 | 2 |
| 2021-02 | 2 | 2 |
| 2021-01 | 2 | 2 |
| 2020-12 | 2 | 2 |
| 2020-11 | 1 | 1 |
| 2020-10 | 1 | 1 |
Production units (1)
Registration history
2020-11-17
Addresses
2020-09-21
Addresses
2020-09-21
Name history: Neumirna Therapeutics ApS
2020-09-21
Company registered
Attributes
Owner registration under 5%
No
Purpose
Selskabets formål er forskning, udvikling og kommercialisering af lægemidler.
First financial period end
2021-12-31
First financial period start
2020-09-21
Registered capital
40,000 DKK; 48,820 DKK; 106,914 DKK; 132,144 DKK; 193,816 DKK
Share classes
No; Yes; Yes; Yes; Yes
Capital currency
DKK
Partly paid capital
No
Covered by AML/CTF act
Not covered
Pseudo CVR number
No
Financial year end
31.12
Financial year start
01.01
Audit opted out
No
Signing rule
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse.; Selskabet tegnes af en direktør i forening med bestyrelsesformanden eller af den samlede bestyrelse.
Latest articles date
2020-09-21; 2021-05-12; 2021-11-12; 2023-01-02; 2024-03-06; 2025-01-10; 2025-05-06; 2025-05-07; 2025-05-15; 2025-08-11; 2025-09-15; 2025-12-18
Similar companies
Searching...
Didn't find what you need? Try searching
Vehicles